Lv41
680 积分 2022-11-21 加入
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
6小时前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
19天前
已完结
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
1个月前
已完结
Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects
1个月前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
1个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
1个月前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
1个月前
已完结
Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway
2个月前
已完结
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
2个月前
已完结
皖公网安备34019202002308
